PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT00093600 · COMPLETED
Trial details
- NCT number
- NCT00093600
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2011-06-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.